Within 10 years of Crohn's disease diagnosis, up to 50% of people will require surgery, with ileocaecal or ileocolonic resection being the most common procedure.1 Surgery is not curative and disease ...

While India must put in place the best possible dispute resolution system, there is a need to further liberalise the policy ...

The FDA is set to give its decision on SNY and REGN's sBLA for Dupixent for chronic spontaneous urticaria on April 18, 2025.

Memphis-Shelby County Schools is suing multiple drug companies. Attorneys call it a mass action lawsuit, with nearly 100 other school districts across the country fighting ...

November is Diabetes Awareness Month; it’s a disease that affects millions of people across the United States – both with ...

One of the primary challenges in the regulatory affairs of the pharmaceutical industry is keeping pace with the ever-evolving regulatory landscape.

"Companies like Novartis, BMS, Sanofi, Amgen, Roche, Sandoz, Thermofisher, Bayer, and Zoetis have their centres here that are ...

Big pharmas are not deterred by China’s increasingly complex business environment. Instead, they are changing strategies to ...

With several high-profile manufacturing outlays already in the books in Europe this year, Sanofi is returning to the bloc in ...

Zucara Therapeutics Inc., a diabetes life sciences company developing ZT-01, the first once-daily therapeutic to prevent hypoglycemia (low blood glucose levels) in people with diabetes, announced that ...

If Kennedy is confirmed, we may lower our US vaccine sales estimates, although we don’t think reductions would be ...

The context: Last week, shares in US vaccine manufacturers Pfizer and Moderna, as well as in European counterparts GSK and ...